journal article·2021-10

An Engineered Patient‐Derived Tumor Organoid Model That Can Be Disassembled to Study Cellular Responses in a Graded 3D Microenvironment

Natalie Landon‐Brace, Jose L. Cadavid, Simon Latour, Ileana L. Co, Darren Rodenhizer, Nancy T. Li, Nila C. Wu, Eryn Bugbee, Aleks Chebotarev, Ji Zhang, Bradly G. Wouters, Alison P. McGuigan

Advanced Functional Materials· Volume 31· Issue 41
Publisher page

Abstract

Abstract Patient‐derived organoids (PDOs) are emerging as powerful models to capture the genetic heterogeneity of human tumors. However, the self‐assembling nature of PDOs limits their use in studies of the impact of microenvironmental heterogeneity on tumor cell function. Here, a paper‐based model, the Tissue Roll for Analysis of Cellular Environment and Response (TRACER) is adapted, using patterned polymer infiltration, to enable controlled assembly and disassembly of organoid structures to study the impact of both genetic and microenvironmental heterogeneity on tumor cell behavior. In the adapted platform (TRACER2), pancreatic cancer PDOs establish oxygen gradients across the tissue and in response exhibit graded cell viability, proliferation, hypoxia‐response gene transcription, and response to gemcitabine therapy. Further, PDOs retrieved from the hypoxic regions of the TRACER2 cultures show graded transcriptional changes in immunosuppression‐related genes and upon co‐culture, after TRACER2 disassembly, induce graded functional changes in Jurkat cells and macrophage cells. Therefore, TRACER2 offers a novel platform to dissect the effects of microenvironmental parameters on tumor cell function.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer Cells and Metastasis · 3D Printing in Biomedical Research · Cancer Genomics and Diagnostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Biomedical Engineering University of Toronto Toronto ON M5S 3G9 Canada

Department of Chemical Engineering and Applied Chemistry University of Toronto Toronto ON M5S 3E5 Canada

Princess Margaret Cancer Centre University Health Network and Department of Radiation Oncology and Department of Medical Biophysics University of Toronto Toronto ON M5G 2M9 Canada

Funding

Ontario Centres of Excellence · Canada First Research Excellence Fund · Canadian Institutes of Health Research

References (65)

Show source-provided references
1. 10.1002/adhm.20170117410.1002/adhm.201701174 ↗
2. 10.1038/s41598-019-54849-w10.1038/s41598-019-54849-w ↗
3. 10.1038/s41588-019-0566-910.1038/s41588-019-0566-9 ↗
4. 10.1136/gutjnl-2016-31195410.1136/gutjnl-2016-311954 ↗
5. 10.1186/s12943-019-1089-910.1186/s12943-019-1089-9 ↗
6. 10.1038/s41591-018-0014-x10.1038/s41591-018-0014-x ↗
7. 10.1038/s41571-020-0363-510.1038/s41571-020-0363-5 ↗
8. 10.1038/s41416-019-0705-110.1038/s41416-019-0705-1 ↗
9. 10.1016/B978-0-12-818128-7.00019-810.1016/B978-0-12-818128-7.00019-8 ↗
10. 10.1038/s41568-018-0007-610.1038/s41568-018-0007-6 ↗
11. 10.1158/2159-8290.CD-18-034910.1158/2159-8290.CD-18-0349 ↗
12. 10.1038/s41598-020-59368-710.1038/s41598-020-59368-7 ↗
13. 10.1038/s41467-019-10148-610.1038/s41467-019-10148-6 ↗
14. 10.1073/pnas.161133811310.1073/pnas.1611338113 ↗
15. 10.1038/nmeth108510.1038/nmeth1085 ↗
16. 10.1073/pnas.122140311010.1073/pnas.1221403110 ↗
17. 10.1021/acs.biomac.7b0142210.1021/acs.biomac.7b01422 ↗
18. 10.1039/c1ib00128k10.1039/c1ib00128k ↗
19. 10.1039/C9LC00270G10.1039/C9LC00270G ↗
20. 10.1073/pnas.121018210910.1073/pnas.1210182109 ↗
21. 10.1073/pnas.161560111410.1073/pnas.1615601114 ↗
22. 10.1038/nmat448210.1038/nmat4482 ↗
23. 10.1073/pnas.091066610610.1073/pnas.0910666106 ↗
24. 10.1371/journal.pone.001894010.1371/journal.pone.0018940 ↗
25. 10.1038/s41596-018-0022-910.1038/s41596-018-0022-9 ↗
26. 10.1038/nmat400910.1038/nmat4009 ↗
27. 10.1038/srep4208810.1038/srep42088 ↗
28. 10.1016/j.stem.2017.12.00910.1016/j.stem.2017.12.009 ↗
29. 10.1038/nm.397310.1038/nm.3973 ↗
30. 10.1021/ac400161j10.1021/ac400161j ↗
31. 10.1016/S0376-7388(00)85117-010.1016/S0376-7388(00)85117-0 ↗
32. 10.1088/1758-5090/ab47e810.1088/1758-5090/ab47e8 ↗
33. 10.1038/nature0487110.1038/nature04871 ↗
34. 10.1038/nrc306410.1038/nrc3064 ↗
35. 10.1186/s40169-019-0226-910.1186/s40169-019-0226-9 ↗
36. 10.1016/S0076-6879(02)52003-610.1016/S0076-6879(02)52003-6 ↗
37. 10.1088/1758-5090/8/4/04500810.1088/1758-5090/8/4/045008 ↗
38. 10.1038/s41388-018-0304-210.1038/s41388-018-0304-2 ↗
39. 10.1158/1535-7163.MCT-12-076710.1158/1535-7163.MCT-12-0767 ↗
40. 10.1186/s13058-016-0686-410.1186/s13058-016-0686-4 ↗
41. 10.1158/0008-5472.CAN-19-095010.1158/0008-5472.CAN-19-0950 ↗
42. 10.3748/wjg.v25.i2.20510.3748/wjg.v25.i2.205 ↗
43. 10.1158/0008-5472.CAN-11-138310.1158/0008-5472.CAN-11-1383 ↗
44. 10.3389/fimmu.2018.0097810.3389/fimmu.2018.00978 ↗
45. 10.1177/194760191142365410.1177/1947601911423654 ↗
46. 10.1515/rjim-2015-002710.1515/rjim-2015-0027 ↗
47. 10.1038/ni.179010.1038/ni.1790 ↗
48. 10.1111/j.1600-065X.2010.00923.x10.1111/j.1600-065X.2010.00923.x ↗
49. 10.1158/1078-0432.CCR-06-274610.1158/1078-0432.CCR-06-2746 ↗
50. 10.1038/s41392-020-0144-810.1038/s41392-020-0144-8 ↗
51. 10.3389/fcell.2020.60720910.3389/fcell.2020.607209 ↗
52. 10.1158/0008-5472.CAN-13-099210.1158/0008-5472.CAN-13-0992 ↗
53. 10.1016/j.biomaterials.2015.02.01210.1016/j.biomaterials.2015.02.012 ↗
54. 10.1364/BOE.38291110.1364/BOE.382911 ↗
55. 10.1021/acs.analchem.8b0248610.1021/acs.analchem.8b02486 ↗
56. 10.1039/C9BM02017A10.1039/C9BM02017A ↗
57. 10.1016/j.biomaterials.2018.01.03810.1016/j.biomaterials.2018.01.038 ↗
58. 10.1016/j.cell.2013.11.02910.1016/j.cell.2013.11.029 ↗
59. 10.1007/978-1-4939-2519-3_810.1007/978-1-4939-2519-3_8 ↗
60. 10.1093/bioinformatics/btp18410.1093/bioinformatics/btp184 ↗
61. 10.1016/0360-3016(95)02006-310.1016/0360-3016(95)02006-3 ↗
62. 10.1016/j.biomaterials.2019.11957210.1016/j.biomaterials.2019.119572 ↗
63. 10.1016/S0076-6879(06)06054-X10.1016/S0076-6879(06)06054-X ↗
64. 10.1186/s12865-017-0214-z10.1186/s12865-017-0214-z ↗
65. 10.1667/RR1207.110.1667/RR1207.1 ↗